THE LATEST CANCER TREATMENT, NK CELL THERAPY, IS DEBUTTED BY MALAYSIA-SOUTH KOREA COLLABORATION
The Memorandum of Agreement (MoA) was signed at the Hospital Universiti Kebangsaan Malaysia between Universiti Kebangsaan Malaysia (UKM) and NK Biocell Sdn. Bhd (HUKM). UKM can develop MYJ1633, which contains NK cells and NK T cells, thanks to this arrangement (NKT Cell). It has the potential to be utilised to treat cancer patients. There are…